Cited by 25Neurogenesis and neuroplasticity mechanismsMultiple Sclerosis Research StudiesCellular transport and secretion

Cathepsin D deficiency delays central nervous system myelination by inhibiting proteolipid protein trafficking from late endosome/lysosome to plasma membrane

Open access
Guo, Da-Zhi, Xiao, Lin, Liu, Yi-Jun, Shen, Chen, Lou, Hui-Fang, Lv, Yan, Pan, Shu-Yi·2018·Experimental & Molecular Medicine

Abstract

This study aimed to investigate the role of cathepsin D (CathD) in central nervous system (CNS) myelination and its possible mechanism. By using CathD knockout mice in conjunction with immunohistochemistry, immunocytochemistry and western blot assays, the myelination of the CNS and the development of oligodendrocyte lineage cells in vivo and in vitro were observed. Endocytosis assays, real-time-lapse experiments and total internal reflection fluorescence microscopy were used to demonstrate the location and movement of proteolipid protein in oligodendrocyte lineage cells. In addition, the relevant molecular mechanism was explored by immunoprecipitation. The increase in Fluoromyelin Green staining and proteolipid protein expression was not significant in the corpus callosum of CathD−/− mice at the age of P11, P14 and P24. Proteolipid protein expression was weak at each time point and was mostly accumulated around the nucleus. The number of oligodendrocyte lineage cells (olig2+) and mature oligodendrocytes (CC1+) significantly decreased between P14 and P24. In the oligodendrocyte precursor cell culture of CathD−/− mice, the morphology of myelin basic protein-positive mature oligodendrocytes was simple while oligodendrocyte precursor cells showed delayed differentiation into mature oligodendrocytes. Moreover, more proteolipid protein gathered in late endosomes/lysosomes (LEs/Ls) and fewer reached the plasma membrane. Immunohistochemistry and immunoelectron microscopy analysis showed that CathD, proteolipid protein and VAMP7 could bind with each other, whereas VAMP7 and proteolipid protein colocalized with CathD in late endosome/lysosome. The findings of this paper suggest that CathD may have an important role in the myelination of CNS, presumably by altering the trafficking of proteolipid protein. Cathepsin D regulates the transport of the major component of myelin, proteolipid protein (PLP), to the cell membrane. The enzyme cathepsin D is involved in the breakdown of proteins but little is known about how mutations in cathepsin D are associated with fatal neurological diseases. A team of Chinese researchers led by Shu-Yi Pan at the Navy General Hospital of PLA in Beijing examined the effects of cathepsin D deficiency on the formation of a protective sheath around nerves, a process known as myelination, in mice. They found a marked decrease in the number of mature myelin-producing cells in the brains of mice lacking cathepsin D. Furthermore, in these cells PLP-containing vesicles were transported more slowly towards the plasma membrane than in the controls, highlighting a potential mechanism through which cathepsin D regulates myelination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2017.291

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many LSDs can feature neurodevelopmental symptoms, such as autism and intellectual disability.

    “Many LSDs can feature neurodevelopmental symptoms, such as autism and intellectual disability.67–69”

    From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [67]

    The Introduction links cathepsin D mutations to neurological disease in human infants and to some lysosomal storage disorders; the Results report delayed CNS myelination in cathepsin D–deficient mice. These passages support a developmental neurological connection, but do not establish that many lysosomal storage disorders feature autism or intellectual disability. (LLM, conf=0.80)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. Reid WA, Valler MJ, Kay J. Immunolocalization of cathepsin D in normal and neoplastic human tissues. J Clin Pathol 1986; 39: 1323–1330. 3543065 PMC1140796
  2. Chen L, Li H, Liu W, Zhu J, Zhao X, Wright E et al. Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. Carcinogenesis 2011; 32: 986–994. 21470957 PMC3128558
  3. Kim SJ, Kim KH, Ahn ER, Yoo BC, Kim SY. Depletion of cathepsin D by transglutaminase 2 through protein cross-linking promotes cell survival. Amino Acids 2013; 44: 73–80. 21960143
  4. Fritchie K, Siintola E, Armao D, Lehesjoki AE, Marino T, Powell C et al. Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10). Acta Neuropathol 2009; 117: 201–208. 18762956
  5. Trajkovic K, Dhaunchak AS, Goncalves JT, Wenzel D, Schneider A, Bunt G et al. Neuron to glia signaling triggers myelin membrane exocytosis from endosomal storage sites. J Cell Biol 2006; 172: 937–948. 16520383 PMC2063736
  6. Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y et al. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 2000; 20: 6898–6906. 10995834 PMC6772823
  7. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H et al. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 1995; 14: 3599–3608. 7641679 PMC394433
  8. Haapanen A, Ramadan UA, Autti T, Joensuu R, Tyynela J. In vivo MRI reveals the dynamics of pathological changes in the brains of cathepsin D-deficient mice and correlates changes in manganese-enhanced MRI with microglial activation. Magn Reson Imaging 2007; 25: 1024–1031. 17451907
  9. Partanen S, Haapanen A, Kielar C, Pontikis C, Alexander N, Inkinen T et al. Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis. J Neuropathol Exp Neurol 2008; 67: 16–29. 18091563
  10. Mutka AL, Haapanen A, Kakela R, Lindfors M, Wright AK, Inkinen T et al. Murine cathepsin D deficiency is associated with dysmyelination/myelin disruption and accumulation of cholesteryl esters in the brain. J Neurochem 2010; 112: 193–203. 19845830
  11. Schneider A, Lander H, Schulz G, Wolburg H, Nave KA, Schulz JB et al. Palmitoylation is a sorting determinant for transport to the myelin membrane. J Cell Sci 2005; 118: 2415–2423. 15923654
  12. Weimbs T, Stoffel W. Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 1992; 31: 12289–12296. 1281423
  13. Roussel G, Neskovic NM, Trifilieff E, Artault JC, Nussbaum JL. Arrest of proteolipid transport through the Golgi apparatus in Jimpy brain. J Neurocytol 1987; 16: 195–204. 3305791
  14. Snaidero N, Mobius W, Czopka T, Hekking LH, Mathisen C, Verkleij D et al. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell 2014; 156: 277–290. 24439382 PMC4862569
  15. Feldmann A, Amphornrat J, Schonherr M, Winterstein C, Mobius W, Ruhwedel T et al. Transport of the major myelin proteolipid protein is directed by VAMP3 and VAMP7. J Neurosci 2011; 31: 5659–5672. 21490207 PMC6622839
  16. Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J et al. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2007; 2: 1044–1051. 17546009
  17. Duan S, Anderson CM, Stein BA, Swanson RA. Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci 1999; 19: 10193–10200. 10575016 PMC6782431
  18. Chew LJ, Coley W, Cheng Y, Gallo V. Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J Neurosci 2010; 30: 11011–11027. 20720108 PMC3327889
  19. Simons M, Trotter J. Wrapping it up: the cell biology of myelination. Curr Opin Neurobiol 2007; 17: 533–540. 17923405
  20. Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 2001; 81: 871–927. 11274346
  21. Masson O, Bach AS, Derocq D, Prebois C, Laurent-Matha V, Pattingre S et al. Pathophysiological functions of cathepsin D: targeting its catalytic activity versus its protein binding activity? Biochimie 2010; 92: 1635–1643. 20493920
  22. Barrett AJ. Cathepsin D the lysosomal aspartic proteinase. Ciba Found Symp 1979, 37–50. 399896
  23. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J et al. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 2006; 129: 1438–1445. 16670177
  24. Dimou L, Gallo V. NG2-glia and their functions in the central nervous system. Glia 2015; 63: 1429–1451. 26010717 PMC4470768
  25. Zhao X, He X, Han X, Yu Y, Ye F, Chen Y et al. MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 2010; 65: 612–626. 20223198 PMC2855245
  26. Zhou Q, Choi G, Anderson DJ. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron 2001; 31: 791–807. 11567617
  27. Franceschini I, Vitry S, Padilla F, Casanova P, Tham TN, Fukuda M et al. Migrating and myelinating potential of neural precursors engineered to overexpress PSA-NCAM. Mol Cell Neurosci 2004; 27: 151–162. 15485771
  28. Mi S, Miller RH, Tang W, Lee X, Hu B, Wu W et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009; 65: 304–315. 19334062
  29. McDermott JR, Gibson AM. Degradation of Alzheimer's beta-amyloid protein by human cathepsin D. Neuroreport 1996; 7: 2163–2166. 8930981
  30. Grdovic N, Vidakovic M, Mihailovic M, Dinic S, Uskokovic A, Arambasic J et al. Proteolytic events in cryonecrotic cell death: proteolytic activation of endonuclease P23. Cryobiology 2010; 60: 271–280. 20132808
  31. Fusek M, Vetvicka V. Mitogenic function of human procathepsin D: the role of the propeptide. Biochem J 1994; 303(Pt 3): 775–780. 7980446 PMC1137614
  32. Vashishta A, Ohri SS, Proctor M, Fusek M, Vetvicka V. Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells. Anticancer Res 2006; 26: 4163–4170. 17201128
  33. Vetvicka V, Benes P, Fusek M. Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors. Cancer Gene Ther 2002; 9: 854–863. 12224027
  34. Vetvicka V, Vektvickova J, Fusek M. Effect of human procathepsin D on proliferation of human cell lines. Cancer Lett 1994; 79: 131–135. 8019970
  35. Vetvicka V, Vetvickova J, Benes P. Role of enzymatically inactive procathepsin D in lung cancer. Anticancer Res 2004; 24: 2739–2743. 15517880
  36. Vetvicka V, Vetvickova J, Fusek M. Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development. Breast Cancer Res Treat 1999; 57: 261–269. 10617302
  37. Koike M, Shibata M, Ohsawa Y, Nakanishi H, Koga T, Kametaka S et al. Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol Cell Neurosci 2003; 22: 146–161. 12676526
  38. Szuchet S, Nielsen LL, Domowicz MS, Austin JR 2nd, Arvanitis DL. CNS myelin sheath is stochastically built by homotypic fusion of myelin membranes within the bounds of an oligodendrocyte process. J Struct Biol 2015; 190: 56–72. 25682762
  39. Kippert A, Trajkovic K, Rajendran L, Ries J, Simons M. Rho regulates membrane transport in the endocytic pathway to control plasma membrane specialization in oligodendroglial cells. J Neurosci 2007; 27: 3560–3570. 17392472 PMC6672132
  40. Eng LF, Chao FC, Gerstl B, Pratt D, Tavaststjerna MG. The maturation of human white matter myelin. Fractionation of the myelin membrane proteins. Biochemistry 1968; 7: 4455–4465. 5700665
  41. Norton WT, Poduslo SE. Myelination in rat brain: changes in myelin composition during brain maturation. J Neurochem 1973; 21: 759–773. 4754856
  42. Edgar JM, Anderson TJ, Dickinson PJ, Barrie JA, McCulloch MC, Nave KA et al. Survival of, and competition between, oligodendrocytes expressing different alleles of the Plp gene. J Cell Biol 2002; 158: 719–729. 12177040 PMC2174021
  43. Baron W, Hoekstra D. On the biogenesis of myelin membranes: sorting, trafficking and cell polarity. FEBS Lett 2010; 584: 1760–1770. 19896485
  44. Chaineau M, Danglot L, Proux-Gillardeaux V, Galli T. Role of HRB in clathrin-dependent endocytosis. J Biol Chem 2008; 283: 34365–34373. 18819912 PMC2662242
  45. Hesketh GG, Pérez-Dorado I, Jackson LP, Wartosch L, Schäfer IB, Gray SR et al. VARP is recruited on to endosomes by direct interaction with retromer, where together they function in export to the cell surface. Dev Cell 2014; 29: 591–606. 24856514 PMC4059916
  46. Luzio JP, Parkinson MDJ, Gray SR, Bright NA. The delivery of endocytosed cargo to lysosomes. Biochem Soc Trans 2009; 37: 1019–1021. 19754443
  47. Rossi V, Banfield DK, Vacca M, Dietrich LEP, Ungermann C, D’Esposito M et al. Longins and their longin domains: regulated SNAREs and multifunctional SNARE regulators. Trends Biochem Sci 2004; 29: 682–688. 15544955
  48. Moreau K, Ravikumar B, Renna M, Puri C, Rubinsztein DC. Autophagosome precursor maturation requires homotypic fusion. Cell 2011; 146: 303–317. 21784250 PMC3171170
  49. Arantes RM, Andrews NW. A role for synaptotagmin VII-regulated exocytosis of lysosomes in neurite outgrowth from primary sympathetic neurons. J Neurosci 2006; 26: 4630–4637. 16641243 PMC6674075
  50. Marcet-Palacios M, Odemuyiwa SO, Coughlin JJ, Garofoli D, Ewen C, Davidson CE et al. Vesicle-associated membrane protein 7 (VAMP-7) is essential for target cell killing in a natural killer cell line. Biochem Biophys Res Commun 2008; 366: 617–623. 18042464
  51. Proux-Gillardeaux V, Raposo G, Irinopoulou T, Galli T. Expression of the Longin domain of TI-VAMP impairs lysosomal secretion and epithelial cell migration. Biol Cell 2007; 99: 261–271. 17288539
  52. Chaineau M, Danglot L, Galli T. Multiple roles of the vesicular-SNARE TI-VAMP in post-Golgi and endosomal trafficking. FEBS Lett 2009; 583: 3817–3826. 19837067
  53. Danglot L, Chaineau M, Dahan M, Gendron MC, Boggetto N, Perez F et al. Role of TI-VAMP and CD82 in EGFR cell-surface dynamics and signaling. J Cell Sci 2010; 123: 723–735. 20144992
  54. Martinez-arca S, Alberts P, Zahraoui A, Louvard D, Galli T. Role of tetanus neurotoxin insensitive vesicle-associated membrane protein (TI-VAMP) in vesicular transport mediating neurite outgrowth. J Cell Biol 2000; 149: 889–899. 10811829 PMC2174569
  55. Martinez-Arca S, Rudge R, Vacca M, Raposo G, Camonis J, Proux- Gillardeaux V et al. A dual mechanism controlling the localization and function of exocyticv-SNAREs. Proc Natl Acad Sci USA 2003; 100: 9011–9016. 12853575 PMC166429
  56. Okumura AJ, Hatsuzawa K, Tamura T, Nagaya H, Saeki K, Okumura F et al. Involvement of a novel Q-SNARE, D12, in quality control of the endomembrane system. J Biol Chem 2006; 281(7): 4495–4506. 16354670

Cited by

Sorted by citations

Authors
Guo, D.-Z., Xiao, L., Liu, Y.-J., Shen, C., Lou, H.-F., Lv, Y., & Pan, S.-Y.
Affiliations
  • Second Military Medical University (CN)
  • China National Petroleum Corporation (China) (CN)
  • PLA Navy General Hospital (CN)
Venue
Experimental & Molecular Medicine
Published
2018-03
Volume
50
Issue
3
Pages
e457-e457
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2792017564
Cited by
25
References
3
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 1 · 2018: 1
FWCI
1.01
Type
journal article
Language
en
Open access
Locations
  • Experimental & Molecular Medicine (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (31471013, 81401063)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords
cathepsin D, proteolipid protein, myelination, oligodendrocyte differentiation, protein trafficking, VAMP7, oligodendrocyte precursor cells, myelin basic protein, CNS myelination, lysosomal proteolysis, oligodendrocyte lineage
MeSH terms
Animals, Cathepsin D, Cell Membrane, Central Nervous System, Lysosomes, Myelin Sheath, Proteolipids, Endosomes, Mice, Knockout, Immunoprecipitation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review